Investigating Crimean-Congo Hemorrhagic Fever Virus in Corsica
Dr. Remi Charrel and his team at the Unité des Virus Emergents (UVE) in Aix-Marseille University, France, aimed to assess the risk of Crimean-Congo...
ISIDORe success stories
Community Engagement in the Mpox Response
Dr. Paul Grohma and his team at the Medical University of Vienna have undertaken an important project to evaluate community engagement strategies...
Broad-Spectrum Inhibitors Against CoronavirusesBroad-Spectrum
Dr. Duc Duy Vo and his team at Uppsala University are focused on identifying non-covalent small-molecule inhibitors of the SARS-CoV-2 main protease...
Assessing the Susceptibility of Rats to Mpox Virus
Dr. Barry Rockx and his team at Wageningen Bioveterinary Research, the Netherlands, are investigating the potential for rats to serve as reservoirs...
Mitigating COVID-19 Virulence
Dr. Fernando J. Montero Segovia and his team at the University of Granada, Spain, are researching ways to mitigate COVID-19 virulence by targeting...
Informational Practices and Aspirations of Long COVID Patients
Dr. Jonathan Sobel and his team at the Institute of Global Health, University of Geneva, Switzerland, are conducting a mixed-methods study to...
SARS-CoV-2 Helicase Inhibitors Screening
Dr. Giulio Vistoli and his team at the Department of Pharmaceutical Sciences, University of Milan, Italy, are exploring the therapeutic potential of...
Evaluating Metformin for Pulmonary Tuberculosis treatment
Dr. Nibedita Rath and her team are conducting a randomized, controlled, open-label Phase III trial to evaluate the efficacy and safety of metformin...
Targeted Drug Delivery for SARS-CoV-2
Dr. Veronika Huntosova and her team at the Center for Interdisciplinary Biosciences, Technology and Innovation Park, Pavol Jozef Šafárik...
Advancing Regulatory Roadmaps for DNA Vaccine Development
Dr. Mireia López Siles and her team at the Universitat de Girona, Spain, are spearheading the development of KlebsiGene, a prophylactic DNA vaccine...